Nextstellis Combined Oral Contraceptive from Japan
Nextstellis contains estetrol (novel estrogen hormone) and drospirenone progestin for contraception. First new estrogen in 50 years. Hormone combination fits HTS 3006.60.00.00.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Novel API requires additional toxicological data
• Estetrol metabolism studies support classification
• Drospirenone component familiar from prior approvals